http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-8100572-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1981-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1981-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NL-8100572-A |
| titleOfInvention | PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH A SECRETION-ANTI-ULCUS-PREVENTING EFFECT THAT A PYRIDOBENZODIAZEPINONE SUBSTITUTED BY A DIALLYLAMINOACYL GROUP AND / OR A PHYSIOLOGICALLY PROPERTY |
| abstract | Novel diallylaminoalkanoylamides of formula (I): (where R1 is H or 1-4C alkyl; R2 and R3 are independently H or halogen; Y is =CH- or N; A is methylene or ethylene). Prefd. cpds. include 11-diallylaminoacetyl-5,11-dihydro-5-methyl-6H-pyrido- 2,3-b 1,4 benzodiaze-pin-6-one. Cpds. pref. prepd. by reacting a haloalkanoyl of formula (I) (where -N(CH2-CH=CH2)2 is replaced by halogen) with a diallylamine and opt. converting to its (in)organic acid addn. salts. Cpds. inhibit ulcers. |
| priorityDate | 1969-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.